[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603081":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":10,"responsibleParty":19,"collaborators":10,"id":23,"slug":24,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":27,"acronym":28,"eligibilityCriteria":29,"healthyVolunteers":25,"sex":30,"minAge":31,"maxAge":32,"enrollmentInfo":33,"targetDuration":10,"studyType":36,"phases":10,"briefSummary":37,"conditions":38,"keywords":10,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"patient diagnosed with aplastic anemia from July 2023 to sept 2025",null,{"label":12,"type":10,"description":10,"interventionNames":10},"patient diagnosed with aplastic anemia from Sept 2025 to July 2026",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Marwa M Abozaid, master","CONTACT","+201146679786","marwaabozaid39@gmail.com",{"type":20,"investigatorFullName":21,"investigatorTitle":22,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Marwa Mohamed Abozaid","Resident doctor","100603081","assesment-of-treatment-outcomes-of-aquired-aplastic-anemia-in-children--a-retrospective-and-prospective-cohort-100603081",false,"NCT07131878","Assesment of Treatment Outcomes of Aquired Aplastic Anemia in Children : A Retrospective and Prospective Cohort","TTT","Inclusion Criteria:\n\n* Children aged 1-18 years diagnosed with acquired aplastic anemia, as confirmed by bone marrow examination and fulfilling diagnostic criteria (e.g., bone marrow cellularity \\\u003C25% and at least two of the following: absolute neutrophil count \\\u003C500\u002FμL, platelet count \\\u003C20,000\u002FμL, absolute reticulocyte count \\\u003C60,000\u002FμL)123.\n* The bone marrow biopsy should be compitable with diagnosis\n* Diagnosed and\u002For treated at Assiut University Children's Hospital between Agust 2023 and Augst 2026.\n* Patients with complete medical records, including diagnostic, laboratory, and treatment data\n\nExclusion Criteria:\n\n* Patients with inherited bone marrow failure syndromes (e.g., Fanconi anemia, dyskeratosis congenita) as confirmed by genetic testing or family history21.\n* Patients with incomplete or missing essential data in their medical records.\n* Patients diagnosed outside the specified study period or managed primarily at other institutions.\n* Patinets with neoplastic or granulomatous disease involving the bone marrow, systemic lupus erythematosus, AIDS, hypersplenism or other conditions associated with pancytopenia such as myelodysplastic syndrome,and paroxysmal nocturnal hemoglobinuria.\n* Patients exposed to antineoplastic chemotherapy or radiotherapy were excluded","ALL","1 Year","18 Years",{"count":34,"type":35},35,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to to assess of treatment Outcomes of Aquired Aplastic Anemia in children",[39],"Aplastic Anaemia (AA)","NOT_YET_RECRUITING","2025-08-13",{"date":43,"type":44},"2025-08-20","ACTUAL",{"date":46,"type":35},"2025-09-15",{"date":48,"type":35},"2028-01-15",{"name":5,"class":6}]